Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Where Will It End? Lilly’s US Price Concessions Increase 30% In 2016

Mar 02 2017

• By Cathy Kelly

Related Content

Drug Pricing: PhRMA Report Aims To Shift Focus To Supply Chain

Jan 20 2017

Price Rebates Will Continue As ‘Fact Of Life’ In Drug Contracting

Jan 16 2017

Janssen's Drug Pricing Report Emphasizes Value Of Rebates

Mar 01 2017

Lilly’s Insulin Discounts Target High-Deductible Insurance Gaps

Dec 13 2016

Pfizer’s Read Criticizes Rebates Amid Changing Market Dynamics

Nov 01 2016

Value-Based Contracting Needs Federal Safe Harbors To Flourish, Lilly Says

Jun 15 2016

Related Companies

Eli Lilly and Company

Express Scripts Holding Company

Pfizer Inc.

Allergan plc

Novo Nordisk A/S

AbbVie Inc.

Johnson & Johnson

Additional Topics

United States Policy Pricing Debate Market Access

More from Pricing Debate

More from Market Access

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window